PROBIOTIX HEALTH LS-05 (X90) — Financial Flexibility Index
Latest as of December 2024:
-4.13x
PROBIOTIX HEALTH LS-05 (X90) has a Financial Flexibility Index of -4.13x as of December 2024. Free cash flow of €-1.05 Million (operating CF €-1.06 Million minus capex €10.00K) represents -4% of total liabilities (€254.00K).
Financial Flexibility Index
-4.13x
Free Cash Flow / Total Liabilities
Free Cash Flow
€-1.05 Million
Operating CF − Capex
Total Liabilities
€254.00K
EUR
Capital Expenditures
€10.00K
EUR
PROBIOTIX HEALTH LS-05 Financial Flexibility Index (2022–2024)
Historical Financial Flexibility Index trend for PROBIOTIX HEALTH LS-05 across 3 annual periods. See X90 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for PROBIOTIX HEALTH LS-05 (2022–2024)
Year-by-year free cash flow to debt coverage for PROBIOTIX HEALTH LS-05. For the full company profile including market capitalisation, see PROBIOTIX HEALTH LS-05 (X90) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -4.13x | €-1.05 Million | €-1.06 Million | €254.00K | ▼ -1013.4% |
| 2023 | -0.37x | €-238.00K | €-238.00K | €641.00K | ▲ +78.0% |
| 2022 | -1.69x | €-591.94K | €-638.02K | €350.91K | — |
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities